Compare BHVN & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHVN | PWP |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2022 | 2020 |
| Metric | BHVN | PWP |
|---|---|---|
| Price | $9.43 | $18.12 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $29.08 | $23.50 |
| AVG Volume (30 Days) | ★ 1.7M | 1.0M |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | 26.08 | ★ 138.52 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $28.86 |
| Revenue Next Year | N/A | $18.95 |
| P/E Ratio | ★ N/A | $918.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.48 | $15.74 |
| 52 Week High | $18.57 | $25.93 |
| Indicator | BHVN | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 36.16 |
| Support Level | $9.26 | $16.59 |
| Resistance Level | $10.22 | $18.51 |
| Average True Range (ATR) | 0.71 | 1.23 |
| MACD | -0.05 | -0.47 |
| Stochastic Oscillator | 19.55 | 5.07 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.